Silver Nanoparticles Protect Against Genotoxicity from Cytosine Arabinoside
Author Information
Author(s): Castañeda-Yslas Idalia Yazmin, Torres-Bugarín Olivia, Arellano-García María Evarista, Ruiz-Ruiz Balam, García-Ramos Juan Carlos, Toledano-Magaña Yanis, Pestryakov Alexey, Bogdanchikova Nina
Primary Institution: Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México
Hypothesis
This study aims to evaluate if silver nanoparticles can protect against the genotoxic effects of cytosine arabinoside.
Conclusion
Silver nanoparticles significantly reduce the genotoxic damage caused by cytosine arabinoside in mice.
Supporting Evidence
- Silver nanoparticles reduced the frequency of micronucleated reticulocytes by 3.7 times.
- Silver nanoparticles decreased the frequency of accumulated erythrocytes by 2 times.
- Previous research showed that silver nanoparticles can mitigate the genotoxic effects of other cancer drugs.
Takeaway
This study shows that tiny silver particles can help protect mice from the harmful effects of a cancer drug.
Methodology
An erythrocyte micronucleus assay was conducted on BALB/c mice to evaluate the protective effects of silver nanoparticles against cytosine arabinoside.
Limitations
The study did not test uncoated silver nanoparticles or PVP alone.
Participant Demographics
Male BALB/c mice, 5 to 6 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website